New rectal gel could offer On-Demand HIV protection without daily pills
NCT ID NCT06560684
First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 4 times
Summary
This study tests two ways to prevent HIV: a rectal gel used before sex and daily pills. About 150 men will try each method for 8 weeks to see which is safer, easier to use, and more acceptable. The goal is to give people more choices for on-demand HIV prevention.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TENOFOVIR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Alabama CRS (Site ID# 31788)
Birmingham, Alabama, 35222, United States
-
Chapel Hill CRS (3201)
Chapel Hill, North Carolina, 27599-7215, United States
-
Fenway Health (FH) CRS
Boston, Massachusetts, 02215-4302, United States
-
Hope Clinic CRS
Lawrenceville, Georgia, 30046, United States
-
Johns Hopkins University CRS
Baltimore, Maryland, 21287, United States
-
UCLA CARE Center CRS
Los Angeles, California, 90035, United States
-
University of Pittsburgh CRS
Pittsburgh, Pennsylvania, 15213, United States
-
Weill Cornell Chelsea CRS
New York, New York, 10011, United States